Previous close | 143.82 |
Open | 144.42 |
Bid | 146.12 x 100 |
Ask | 146.52 x 100 |
Day's range | 143.47 - 146.34 |
52-week range | 110.74 - 159.52 |
Volume | |
Avg. volume | 102,009 |
Market cap | 4.743B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 43.67 |
EPS (TTM) | 3.35 |
Earnings date | 03 May 2024 |
Forward dividend & yield | 0.79 (0.55%) |
Ex-dividend date | 26 Dec 2023 |
1y target est | 154.33 |
First Professional Sports Partnership for VitaCholine® encompasses rights across regions including the United States and the United Kingdom.MONTVALE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- The New York Jets announced a partnership with VitaCholine, a Balchem Human Nutrition and Health brand of the essential nutrient choline, as Proud Partner of the team. This agreement marks VitaCholine’s first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional s
MONTVALE, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will attend the conference. About Balchem Corporation Balchem Cor
MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today published its 2023 Sustainability Report, highlighting the Company's Corporate Social Responsibility initiatives and accomplishments. Guided by our core values and our vision of making the world a healthier place, our Sustainability Report demonstrates the Company's continuing promise to provide our employees, customers, shareholders and the communities within which we operate with information on Balchem’